116 related articles for article (PubMed ID: 37309171)
1.
Li N; Chu J; Hu K; Zhang H; Li N; Chu JF; Hu KY; Zhang HY
J Biosci; 2023; 48():. PubMed ID: 37309171
[TBL] [Abstract][Full Text] [Related]
2. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.
Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK
Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990
[TBL] [Abstract][Full Text] [Related]
3. Abnormal spindle-like microcephaly-associated protein enhances cell invasion through Wnt/β-catenin-dependent regulation of epithelial-mesenchymal transition in non-small cell lung cancer cells.
Xia C; Xu X; Ding Y; Yu C; Qiao J; Liu P
J Thorac Dis; 2021 Apr; 13(4):2460-2474. PubMed ID: 34012593
[TBL] [Abstract][Full Text] [Related]
4. ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Wu B; Hu C; Kong L
Exp Ther Med; 2021 Oct; 22(4):1154. PubMed ID: 34504599
[TBL] [Abstract][Full Text] [Related]
5. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
6. ASPM facilitates colorectal cancer cells migration and invasion by enhancing β-catenin expression and nuclear translocation.
Wang L; Hu XD; Li SY; Liang XY; Ren L; Lv SX
Kaohsiung J Med Sci; 2022 Feb; 38(2):129-138. PubMed ID: 34741399
[TBL] [Abstract][Full Text] [Related]
7. Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell Lung Cancers.
Jang SH; Jiang Y; Shin S; Jung SH; Jung CK; Chung YJ
Yonsei Med J; 2019 Apr; 60(4):326-335. PubMed ID: 30900418
[TBL] [Abstract][Full Text] [Related]
8. ASPM is a predictor of overall survival and has therapeutic potential in endometrial cancer.
Zhou JW; Wang H; Sun W; Han NN; Chen L
Am J Transl Res; 2020; 12(5):1942-1953. PubMed ID: 32509189
[TBL] [Abstract][Full Text] [Related]
9. ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
Wu J; He Z; Zhu Y; Jiang C; Deng Y; Wei B
Curr Cancer Drug Targets; 2021; 21(1):80-89. PubMed ID: 32933462
[TBL] [Abstract][Full Text] [Related]
10. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Wang A; Chen X; Li D; Yang L; Jiang J
J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.
Deng R; Li J; Zhao H; Zou Z; Man J; Cao J; Yang L
J Clin Lab Anal; 2021 Nov; 35(11):e24022. PubMed ID: 34606125
[TBL] [Abstract][Full Text] [Related]
13. ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation.
Zhang H; Yang X; Zhu L; Li Z; Zuo P; Wang P; Feng J; Mi Y; Zhang C; Xu Y; Jin G; Zhang J; Ye H
FEBS Open Bio; 2021 Oct; 11(10):2784-2799. PubMed ID: 34428354
[TBL] [Abstract][Full Text] [Related]
14. GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma.
Ge L; Chen W; Cao W; Liu G; Zhang Q; Zhuang J; Zhang M; Yang J; Guo S; Zhao X; Guo H
Cancer Biomark; 2018; 22(3):395-403. PubMed ID: 29865032
[TBL] [Abstract][Full Text] [Related]
15. ASPM Promotes the Progression of Anaplastic Thyroid Carcinomas by Regulating the Wnt/
Jiang L; Zhang S; An N; Chai G; Ye C
Int J Endocrinol; 2022; 2022():5316102. PubMed ID: 35387319
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma.
Cui XF; Cui XG; Leng N
J Toxicol Pathol; 2019 Oct; 32(4):245-251. PubMed ID: 31719751
[TBL] [Abstract][Full Text] [Related]
17. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
[TBL] [Abstract][Full Text] [Related]
18. FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.
Tsimafeyeu I; Khasanova A; Stepanova E; Gordiev M; Khochenkov D; Naumova A; Varlamov I; Snegovoy A; Demidov L
Clin Transl Oncol; 2017 Feb; 19(2):265-268. PubMed ID: 27379982
[TBL] [Abstract][Full Text] [Related]
19. Activation of assembly factor for spindle microtubules triggers progression of renal cell carcinoma via Wnt3a pathway.
Cao Z; Li Y; Xu C; Zhang Z; Wang Z; Ma Z; Xu P; Sun X; He X; Zhang J; Jiang H; Li G
J Cancer; 2023; 14(17):3248-3257. PubMed ID: 37928425
[TBL] [Abstract][Full Text] [Related]
20. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis.
Hsu CC; Liao WY; Chan TS; Chen WY; Lee CT; Shan YS; Huang PJ; Hou YC; Li CR; Tsai KK
J Pathol; 2019 Dec; 249(4):498-508. PubMed ID: 31465125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
